BREAKING: Target Test Prep releases Brand New 2026 On Demand GMAT prep course

Redeem

Target Test Prep · GMAT

Choose how you want to prepare

Learn live with an expert or move at your own pace. Every option includes the complete TTP study system.

★★★★★5.0559 reviews
Vote for Target Test Prep, Newsweek Readers’ Choice Awards 2026
NEWSWEEK READERS’ CHOICE 2026

BIG NEWS! Target Test Prep has been nominated, and they’d love your vote!

TTP has worked incredibly hard to build the best test prep experience possible, and winning Newsweek’s 2026 Readers’ Choice Award for Best Test Prep would mean a lot to them. If TTP has helped you, they’d be incredibly grateful for your vote. You can vote once each day through September 9.

Vote for TTP
GMATLiveTeach 7 seats left
Chris Peckover
NEXT LIVE COHORT

Oct 13 to Jan 7, 2027

with Chris Peckover

Schedule
Tue, Thu · 8:00 to 10:00 PM ET
Included
40 live hours + 6 months of GMAT OnDemand
  • Live instruction and real-time questions
  • Class recordings and assigned practice
View class & enroll
Limited cohort · enrollment openTarget Test Prep
EALiveTeach 5 seats left
Logan Thompson
EXECUTIVE ASSESSMENT

Sep 6 to Dec 6, 2026

with Logan Thompson

Schedule
Sun · 9:30 AM to 12:30 PM ET
Included
40 hours of live online classes plus six months of access to the complete TTP EA OnDemand course.
  • 165+ EA Score Guarantee
  • 4,100+ Quant, Verbal, and Integrated Reasoning practice questions
  • 400+ hours of in-depth video lessons
  • 3,000+ step-by-step video solutions
View EA class & enroll
Limited cohort · enrollment openTarget Test Prep
GMATOnDemand Start anytime
SELF-PACED MASTERCLASS

Target Test Prep GMAT OnDemand

Complete access from day one. Study on your schedule.

715+ score guarantee
$0to start then $127/mo
  • Personalized study plan and analytics
  • Thousands of lessons and practice questions

Compare the format, schedule, and included access before enrolling. Prices and seat counts shown reflect the supplied offer details.

Asbestosis!

Expert replies
by gmat_for_life » Tue Jun 21, 2016 7:48 pm
Asbestosis, a lung disease developed by people with a known history of exposure to asbestos, has symptoms identical to idiopathic pulmonary fibrosis (IPF). As per a new study, exposure to asbestos could be the reason behind some cases of IPF. Presently, people with asbestosis cannot access the new treatments for IPF, despite the consideration that such treatments work on curing an identical disease. If the findings of the study are confirmed, then people with exposure to asbestos need to be given access to the new treatments for IPF.
Which of the following, if true, provides the strongest reason to believe in the link proposed by the new study?

A. Another study has confirmed that the old treatments for IPF cannot cure asbestosis.
B. The usual treatments for asbestosis do not treat IPF.
C. Since both the diseases have identical symptoms, patients with a known history of exposure to asbestos are more likely to be diagnosed with asbestosis than with IPF.
D. IPF belongs to a group of more than 200 lung diseases known as interstitial lung diseases, a group that includes asbestosis.
E. High rates of IPF deaths have been noted in ship workers working with boilers, wall insulation turbines, gaskets etc., parts made typically of asbestos.

[spoiler]OA is E. Could you guys please explain why option B is incorrect?[/spoiler]
Join the discussion
Source: — Critical Reasoning |

by OptimusPrep » Wed Jun 22, 2016 8:23 pm
gmat_for_life wrote:Asbestosis, a lung disease developed by people with a known history of exposure to asbestos, has symptoms identical to idiopathic pulmonary fibrosis (IPF). As per a new study, exposure to asbestos could be the reason behind some cases of IPF. Presently, people with asbestosis cannot access the new treatments for IPF, despite the consideration that such treatments work on curing an identical disease. If the findings of the study are confirmed, then people with exposure to asbestos need to be given access to the new treatments for IPF.
Which of the following, if true, provides the strongest reason to believe in the link proposed by the new study?

A. Another study has confirmed that the old treatments for IPF cannot cure asbestosis.
B. The usual treatments for asbestosis do not treat IPF.
C. Since both the diseases have identical symptoms, patients with a known history of exposure to asbestos are more likely to be diagnosed with asbestosis than with IPF.
D. IPF belongs to a group of more than 200 lung diseases known as interstitial lung diseases, a group that includes asbestosis.
E. High rates of IPF deaths have been noted in ship workers working with boilers, wall insulation turbines, gaskets etc., parts made typically of asbestos.

[spoiler]OA is E. Could you guys please explain why option B is incorrect?[/spoiler]
Fact 1: Asbestosis is a disease caused by exposure to asbestos and has symptoms similar to IPF.
Fact 2: Asbestos might be the reason behind some cases of IPF.
Fact 3: People with asbestosis cannot access new treatments for IPF.

We need to strengthen the fact2 i.e. the link between IPF and Asbestosis.
If we show that both the diseases are caused by similar things, we can show a link between the two.
Option E does the same by telling that high rates of IPF deaths are noted in people working with parts made of asbestos.
Hence the correct answer.

Option B on the other hand says that the treatments for asbestosis do not treat IPF.
This does not show a link between the two. Moreover we are concerned about the treatment for IPF to be given to the asbestosis patients.
Join the discussion